191 related articles for article (PubMed ID: 30005946)
1. In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.
Mulherkar R; Karabudak A; Ginwala R; Huang X; Rowan A; Philip R; Murphy EL; Clements D; Ndhlovu LC; Khan ZK; Jain P
Vaccine; 2018 Aug; 36(33):5046-5057. PubMed ID: 30005946
[TBL] [Abstract][Full Text] [Related]
2. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
4. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
5. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.
Utz U; Banks D; Jacobson S; Biddison WE
J Virol; 1996 Feb; 70(2):843-51. PubMed ID: 8551623
[TBL] [Abstract][Full Text] [Related]
7. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
[TBL] [Abstract][Full Text] [Related]
9. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
[TBL] [Abstract][Full Text] [Related]
10. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
Kannagi M; Matsushita S; Shida H; Harada S
Leukemia; 1994 Apr; 8 Suppl 1():S54-9. PubMed ID: 8152305
[TBL] [Abstract][Full Text] [Related]
12. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection.
Gessain A
J Neurovirol; 1996 Oct; 2(5):299-306. PubMed ID: 8912206
[TBL] [Abstract][Full Text] [Related]
13. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities
Ma G; Yasunaga JI; Ohshima K; Matsumoto T; Matsuoka M
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167921
[TBL] [Abstract][Full Text] [Related]
14. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
[TBL] [Abstract][Full Text] [Related]
15. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
16. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.
Jeffery KJ; Siddiqui AA; Bunce M; Lloyd AL; Vine AM; Witkover AD; Izumo S; Usuku K; Welsh KI; Osame M; Bangham CR
J Immunol; 2000 Dec; 165(12):7278-84. PubMed ID: 11120862
[TBL] [Abstract][Full Text] [Related]
17. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
[TBL] [Abstract][Full Text] [Related]
18. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
Kannagi M; Shida H; Igarashi H; Kuruma K; Murai H; Aono Y; Maruyama I; Osame M; Hattori T; Inoko H
J Virol; 1992 May; 66(5):2928-33. PubMed ID: 1373197
[TBL] [Abstract][Full Text] [Related]
19. In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.
Sagar D; Masih S; Schell T; Jacobson S; Comber JD; Philip R; Wigdahl B; Jain P; Khan ZK
Vaccine; 2014 May; 32(26):3274-84. PubMed ID: 24739247
[TBL] [Abstract][Full Text] [Related]
20. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
Parker CE; Daenke S; Nightingale S; Bangham CR
Virology; 1992 Jun; 188(2):628-36. PubMed ID: 1374983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
